Logo image of NBLX

Noble Midstream Partners LP (NBLX) Stock Fundamental Analysis

USA - NYSE:NBLX -

15.21
-0.09 (-0.59%)
Last: 5/10/2021, 8:21:48 PM
15.21
0 (0%)
After Hours: 5/10/2021, 8:21:48 PM
Fundamental Rating

2

NBLX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. NBLX has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, NBLX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NBLX was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 5.11%
ROE 13%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 29.94%
PM (TTM) 18.94%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

There is no outstanding debt for NBLX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

NBLX has an Altman-Z score of 0.69. This is a bad value and indicates that NBLX is not financially healthy and even has some risk of bankruptcy.
NBLX has a Debt/Equity ratio of 0.89. This is a neutral value indicating NBLX is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 0.69
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.25 indicates that NBLX may have some problems paying its short term obligations.
A Quick Ratio of 0.25 indicates that NBLX may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.25

More info and screens

4

3. Growth

3.1 Past

The earnings per share for NBLX have decreased strongly by -12.01% in the last year.
The Earnings Per Share has been growing by 32.10% on average over the past years. This is a very strong growth
Looking at the last year, NBLX shows a small growth in Revenue. The Revenue has grown by 6.75% in the last year.
Measured over the past years, NBLX shows a very strong growth in Revenue. The Revenue has been growing by 54.15% on average per year.
EPS 1Y (TTM)-12.01%
EPS 3YN/A
EPS 5Y32.1%
EPS Q2Q%-32.31%
Revenue 1Y (TTM)6.75%
Revenue growth 3YN/A
Revenue growth 5Y54.15%
Sales Q2Q%24.25%

3.2 Future

The Earnings Per Share is expected to decrease by -11.14% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-17.71%
EPS Next 2Y-11.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NBLX Yearly Revenue VS EstimatesNBLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
NBLX Yearly EPS VS EstimatesNBLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

NBLX is valuated cheaply with a Price/Earnings ratio of 5.61.
When comparing the Price/Earnings ratio of NBLX to the average of the S&P500 Index (27.76), we can say NBLX is valued rather cheaply.
NBLX is valuated cheaply with a Price/Forward Earnings ratio of 6.82.
NBLX is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.18, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.61
Fwd PE 6.82
NBLX Price Earnings VS Forward Price EarningsNBLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.85
NBLX Per share dataNBLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

NBLX's earnings are expected to decrease with -11.14% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.17
EPS Next 2Y-11.14%
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.93%, NBLX is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.41, NBLX pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.93%

5.2 History

The dividend of NBLX decreases each year by -19.17%.
NBLX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-19.17%
Div Incr YearsN/A
Div Non Decr YearsN/A
NBLX Yearly Dividends per shareNBLX Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 0.5 1 1.5 2 2.5

5.3 Sustainability

The Dividend Rate of NBLX has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2Y-11.14%
EPS Next 3YN/A

More info and screens

Noble Midstream Partners LP

NYSE:NBLX (5/10/2021, 8:21:48 PM)

After market: 15.21 0 (0%)

15.21

-0.09 (-0.59%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)02-11 2022-02-11/bmo
Inst Owners2.19%
Inst Owner Change0%
Ins Owners37.49%
Ins Owner Change0%
Market Cap1.37B
Analysts46.6
Price Target13.9 (-8.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.93%
Yearly Dividend0.75
Dividend Growth(5Y)-19.17%
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.61
Fwd PE 6.82
P/S 1.68
P/FCF N/A
P/OCF N/A
P/B 1.15
P/tB N/A
EV/EBITDA 6.85
EPS(TTM)2.71
EY17.82%
EPS(NY)2.23
Fwd EY14.66%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS9.06
BVpS13.21
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.17
Profitability
Industry RankSector Rank
ROA 5.11%
ROE 13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 29.94%
PM (TTM) 18.94%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.25
Altman-Z 0.69
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.01%
EPS 3YN/A
EPS 5Y32.1%
EPS Q2Q%-32.31%
EPS Next Y-17.71%
EPS Next 2Y-11.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.75%
Revenue growth 3YN/A
Revenue growth 5Y54.15%
Sales Q2Q%24.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A